News and Trends 23 Jul 2020
Pharma Giant GSK and mRNA Biotech CureVac Ink €1B Deal
GlaxoSmithKline (GSK) has struck a deal worth up to €1B with the German biotechnology company CureVac to co-develop messenger RNA…
David Wilson
About
David Wilson is an Anglo-Australian business and tech specialist whose experience in journalism spans two decades. His stories have run everywhere from the South China Morning Post to Slate and The New York Times. In the 20-teens he ran a successful rehousing campaign for an extended Vietnamese family of slum-dwellers. In his spare time, he does strength training and hangs out with domestic cats.Articles by David Wilson
News and Trends 13 Jul 2020
Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal
The Dutch biotech Kiadis Pharma has licensed an off-the-shelf cell therapy program to the pharma giant Sanofi for up to…
News and Trends 13 Jul 2020
Forbion Raises €185M to Fuel Late-Stage European Biotechs
The Dutch life sciences venture capital firm Forbion has bagged €185M in the first closing of a fund aimed at…
News and Trends 1 Jul 2020
Swiss Regenerative Medicine Biotech Closes €19M Series B
The regenerative medicine startup Cutiss has raised €18.8M (CHF 20M) to commercialize its personalized skin graft treatment for burn patients…
ADVERTISEMENT
News and Trends 22 Jun 2020
Swedish Biotech’s Psoriasis Drug Beats Placebo in Phase II
A new class of drug developed by the Swedish biotech company Affibody has proved better at treating symptoms of psoriasis…